Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers
β Scribed by M. D. Schaller; J. Nussberger; B. Waeber; J. P. Bussien; G. A. Turini; H. Brunner; H. R. Brunner
- Publisher
- Springer
- Year
- 1985
- Tongue
- English
- Weight
- 682 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of the new angiotensin converting enzyme (ACE) inhibitor benazeprikHC1 were evaluated in healthy male volunteers. The single dose kinetics were established from data of 62 subjects receiving an oral 10 mg dose of the drug. The steady state kinetics were investigated in 15 subjec
Zabicipril is a recently introduced angiotensin converting enzyme (ACE) inhibitor, which has been observed in experimental animals to increase diuresis, natriuresis, glomerular filtration rate (GFR) and renal plasma flow (RPF). We have investigated the acute effects of zabicipril on systemic and ren
Potential effects of the coadministration of single doses of aspirin (325mg) and of benazepril hydrochloride (20 mg) on the pharmacokinetics and the metabolism of these two drugs were evaluated in 12 healthy subjects. Plasma concentration profiles of benazepril, its active metabolite benazeprilat, a